Serratia marcescens as a postoperative pathogen

Am J Surg. 1971 Jul;122(1):64-9. doi: 10.1016/0002-9610(71)90350-3.
No abstract available

MeSH terms

  • Ampicillin / therapeutic use
  • Anti-Bacterial Agents / pharmacology
  • Anti-Bacterial Agents / therapeutic use
  • Carbenicillin / therapeutic use
  • Cephalothin / therapeutic use
  • Chloramphenicol / pharmacology
  • Chloramphenicol / therapeutic use
  • Endocarditis, Bacterial / drug therapy
  • Enterobacteriaceae Infections / drug therapy
  • Enterobacteriaceae Infections / etiology*
  • Enterobacteriaceae Infections / prevention & control
  • Gentamicins / pharmacology
  • Gentamicins / therapeutic use
  • Humans
  • Kanamycin / therapeutic use
  • Microbial Sensitivity Tests
  • Nalidixic Acid / pharmacology
  • Nalidixic Acid / therapeutic use
  • Oxytetracycline / therapeutic use
  • Penicillin Resistance
  • Polymyxins / therapeutic use
  • Sepsis / etiology
  • Sepsis / therapy
  • Serratia marcescens / drug effects
  • Serratia marcescens / isolation & purification
  • Serratia marcescens / pathogenicity*
  • Surgical Wound Infection / drug therapy
  • Surgical Wound Infection / etiology
  • Surgical Wound Infection / prevention & control
  • Urinary Tract Infections / drug therapy

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Polymyxins
  • Nalidixic Acid
  • Kanamycin
  • Chloramphenicol
  • Ampicillin
  • Carbenicillin
  • Cephalothin
  • Oxytetracycline